PRRT2 and familial Mediterranean fever: While each disease was represented by a low number of patients, none of the non‐FMF patients (termed “Disease control‐DC” in Fig 6) responded to the two PKC inhibitors by producing large amount of IL‐1β (Fig 6A and B) or by triggering a fast monocyte death (Fig 6C–E, Appendix Fig S10A–C).